Q1 EPS Estimate for X4 Pharmaceuticals Lifted by Analyst
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Analysts at HC Wainwright boosted their Q1 2025 earnings per share estimates for shares of X4 Pharmaceuticals in a research report issued to clients and investors on Thursday, March 27th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of ($0.02) […]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Analysts at HC Wainwright boosted their Q1 2025 earnings per share estimates for shares of X4 Pharmaceuticals in a research report issued to clients and investors on Thursday, March 27th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of ($0.02) […]
